Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.
Press releases published on May 8, 2025

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results
Six posters presented at the American Association for Cancer Research (AACR) annual meeting Appointment of Dr. Sabeen Mekan as Senior Vice President, Clinical Development Reported $321.6 million in cash resources as of March 31, 2025 (compared to $324.2 …

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Encouraging results of Cohort A data from the ASCEND trial presented at ASCO-GI 2025; Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025 Cash runway extending into the third quarter of 2026 with no debt Conference call …

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results
CANTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical …

Fulcrum Therapeutics to Participate in Upcoming May Conferences
CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …

Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
Presented positive 4- and 12-week clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome immune recognition, while continuing to function and persist with …

IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance
Quarterly revenue grew 11% versus prior year quarter - highest growth in ten quarters Adjusted EPS of $0.82 - an increase of 18% to prior year quarter Makes strategic entry into India - launching with leading healthcare client Board authorizes a new $15 …

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
Initiated dose expansion in Phase 1 CARDINAL trial of TERN-701 in 2L+ CML Additional safety and efficacy data including 6-month MMR expected in 4Q25 Phase 2 FALCON trial of TERN-601 for obesity is enrolling well with top-line 12-week weight loss data …

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results
Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of …

Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Topline data from multiple Phase 2 studies expected throughout 2025 • Q2 readout from VTX3232 study in patients with early Parkinson’s disease • H2 readout from VTX2735 study in patients with recurrent pericarditis • H2 readout from VTX3232 study in …

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results
SALT LAKE CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter …

Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update
Strong execution and progress across pipeline with multiple key data read outs expected in 2025 Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in June Phase 3 barzolvolimab CSU studies enrollment ongoing; Phase 3 program in CIndU …

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …

MEDIAIPLUS leads data-driven solutions to close clinical trial information gaps
MEDIAIPLUS uses AI to close clinical trial info gaps, offering data tools that match CROs, aid researchers, and support global pharma with smart solutions. PANGYO, GYEONGGI-DO, SOUTH KOREA, May 8, 2025 /EINPresswire.com/ -- Founded in 2019, MEDIAIPLUS …

Compromiso de IUX con la transparencia y la seguridad de los datos en el trading
IUX refuerza la protección de datos con medidas estrictas en la verificación de identidad y depósitos, asegurando la confidencialidad y seguridad. LIMASSOL, VINCENT, CYPRUS, May 8, 2025 /EINPresswire.com/ -- IUX presta una atención especial a la …

Latin Metals Appoints Eduardo Leon as Vice President of Exploration and Qualified Person
Upsizes Private Placement for Gross Proceeds of $1.3 Million Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. …

MEXC Lists USD1, Accelerating Global Stablecoin Innovation with World Liberty Financial
VICTORIA, Seychelles, May 08, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, announced that it will list World Liberty Financial USD (USD1) in the Innovation Zone on May 9, 2025 (UTC). The USD1/USDT trading pair will also open at …

Burgundy Diamond Mines releases 2024 Socio-Economic Report
CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Burgundy Diamond Mines Limited (ASX:BDM) (Burgundy or the Company) today announced the release of its 2024 Socio-Economic (SEA) Report, highlighting the company’s achievements and progress in the areas of …

Camposol Holding PLC’s Invitation to the First Quarter 2025 Financial Results Presentation
Camposol Holding PLC will announce its preliminary financial results for the first quarter of 2025 on Tuesday, May 27, 2025, at 9:00 a.m. Eastern Time (ET). In connection with this release, Ricardo Naranjo Fernandez, CEO, and Jossue Yesquen Lihim, IRO, …

Bluegrace Energy Bolivia to Finance 100% Green Energy System at FKF’s Industrial Facility in ZOFRATACNA, Peru
Bluegrace backs FKF's shift to renewable energy with full funding for a solar and battery storage system at ZOFRATACNA’s Eco-Industrial Park in Peru. LONDON, GREATER LONDON, UNITED KINGDOM, May 8, 2025 /EINPresswire.com/ -- FRIGORÍFICOS KOBEFOOD S.A.C. …